2-Propylisoindoline-1,3-dione

Catalog No. :
ACOJPW103
CAS No. :
5323-50-2
Molecular Formula :
C11H11NO2
Molecular Weight :
189.21

IUPAC Name:2-propylisoindoline-1,3-dione

2-Propylisoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$52.00Login to see priceIn stockIn stock
1g95%$140.00Login to see priceIn stockIn stock
5g95%$491.00Login to see priceIn stockIn stock
25g95%$2406.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Propylisoindoline-1,3-dione
IUPAC Name2-propylisoindoline-1,3-dione
MDL No.MFCD00014584
Molecular FormulaC11H11NO2
Molecular Weight189.21
SMILESO=C1N(CCC)C(C2=C1C=CC=C2)=O
InChI KeyRLARUBPTQYKZKA-UHFFFAOYSA-N
Synonym1-(N-Phthalimidyl)propane;1H-Isoindole-1,3(2H)-dione, 2-propyl-;2-Propyl-1H-isoindole-1,3(2H)-dione;2-propyl-1h-isoindole-3(2h)-dione;3(2H)-dione,2-propyl-1H-Isoindole-1;n-propyl-phthalimid;Phthalimide,N-propyl-;PROPYL PHTHALIMIDE
CAS No.5323-50-2
PubChem CID79215

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOJPW103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACOJPW103 route product structure diagram
    ACOJPW1035323-50-2 In Stock
Inquiry

2. ACOJPW103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACOJPW103 route product structure diagram
    ACOJPW1035323-50-2 In Stock
Inquiry

Comments (0)